Skip to main content
BGLC logo

BGLC · BioNexus Gene Lab Corp · Held by Funds

Track BGLC — free
$1.21 -0.02 (-1.86%) At close · Oct 20
Market Cap
$3.53M
Shares
2.93M
Volume · Oct 20 1043 Avg daily vol (3M) 11.4K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of BGLC by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 0.08% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.08% 2,368
Index ETFs 0.00% 0
Active ETFs 0.00% 0
Active funds 0.00% 3
Unclassified 0.00% 0
All registered funds 0.08% 2,371
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding BGLC

2 fund positions
Fund Balance Value % of Fund Open
Showing 1–2 of 2 positions
Key facts CIK 1737523 CUSIP 090628306 Visit website Investor relations